Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) CAO Sells 13,770 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan M. Bartolucci sold 13,770 shares of the stock in a transaction on Friday, January 31st. The stock was sold at an average price of $60.00, for a total value of $826,200.00. Following the completion of the transaction, the chief accounting officer now owns 57,237 shares of the company’s stock, valued at approximately $3,434,220. This trade represents a 19.39 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Tempus AI Trading Up 0.3 %

Tempus AI stock opened at $57.39 on Friday. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $79.49. The stock has a fifty day simple moving average of $44.18 and a two-hundred day simple moving average of $48.18.

Analyst Ratings Changes

TEM has been the subject of several research reports. Piper Sandler reiterated a “neutral” rating and issued a $70.00 price target (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Guggenheim began coverage on shares of Tempus AI in a research note on Monday, December 9th. They set a “buy” rating and a $74.00 target price for the company. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and lifted their target price for the company from $45.00 to $65.00 in a report on Monday, November 11th. Wolfe Research initiated coverage on Tempus AI in a research note on Friday, December 13th. They issued an “outperform” rating and a $60.00 price target on the stock. Finally, Needham & Company LLC reiterated a “buy” rating and set a $56.00 price objective on shares of Tempus AI in a research note on Tuesday, January 14th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $56.36.

Institutional Investors Weigh In On Tempus AI

Several large investors have recently bought and sold shares of the business. First Horizon Advisors Inc. purchased a new stake in shares of Tempus AI during the 3rd quarter valued at about $30,000. FNY Investment Advisers LLC purchased a new position in shares of Tempus AI during the fourth quarter valued at approximately $67,000. Vestor Capital LLC bought a new position in Tempus AI during the third quarter valued at approximately $153,000. Stifel Financial Corp purchased a new stake in Tempus AI in the third quarter worth approximately $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new stake in Tempus AI in the 3rd quarter worth approximately $258,000. 24.22% of the stock is currently owned by institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.